Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gleave

Showing results (171-180 of 259) with videos related to

Pageof 26
Sort By:
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 8, 2021
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 15, 2022
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 25, 2026
HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapiesQuang Hieu Duong, Thi Khanh Le, Thi Thom Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of CanadaMichael Organ, Michael Jewett, Joan Basiuk, et al.
Pageof 26

Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Nature Medicine|November 9, 2010
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceHiroshi Tanaka, Evelyn Kono, Chau P Tran, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 8, 2021
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 12, 2019
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 15, 2022
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)Fred Saad, Armen Aprikian, Antonio Finelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 25, 2026
HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapiesQuang Hieu Duong, Thi Khanh Le, Thi Thom Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of CanadaMichael Organ, Michael Jewett, Joan Basiuk, et al.
Pageof 26